A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031

Status:
Completed

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

To investigate the safety and overall tolerability of co-administration two PDE5 inhibitors UK369,003 and sildenafil

Phase 1

Pfizer

Sildenafil Citrate